4//SEC Filing
Sindlev Rene 4
Accession 0001731122-22-001223
CIK 0001527728other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 6:02 AM ET
Size
7.8 KB
Accession
0001731122-22-001223
Insider Transaction Report
Form 4
Sindlev Rene
Director10% Owner
Transactions
- Other
Common Stock
2022-06-08−125,000→ 0 total(indirect: By RS Arving ApS) - Other
Common Stock
2022-06-08−128,493→ 0 total(indirect: By RS Group ApS)
Holdings
- 9,668,351(indirect: By RS Bio ApS)
Common Stock
Footnotes (2)
- [F1]On May 18, 2022, the reporting person entered into a contract to purchase shares in a private transaction. Certain conditions of the transaction were never fulfilled, including delivery of the shares, and on June 8, 2022, the reporting person terminated that contract, resulting in a return to the reporting person of the cash paid.
- [F2]On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract.
Documents
Issuer
Enochian Biosciences Inc
CIK 0001527728
Entity typeother
Related Parties
1- filerCIK 0001709513
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 6:02 AM ET
- Size
- 7.8 KB